Key result
Catheter-directed thrombolysis in intermediate pulmonary embolism achieved a final technical success rate of 98.8% and a 1-year major adverse event rate of 4.0%, with additional mechanical thrombectomy required in 10% of patients.
Why the study?
Catheter directed thrombolysis and thrombectomy are well established for intermediate pulmonary embolism, but the long-term effect of catheter directed thrombolysis remains unknown.
Does catheter directed thrombolysis with alteplase improve technical and clinical outcomes in patients with intermediate pulmonary embolism?
Observational (n=80)
Does catheter directed thrombolysis with alteplase improve technical and clinical outcomes in patients with intermediate pulmonary embolism?
Catheter-directed thrombolysis with alteplase is highly effective for intermediate pulmonary embolism, significantly reducing pulmonary pressures with low 1-year cardiovascular mortality.
Long-term CDT effects in IPE remain unclear; retrospective data from 80 patients are hypothesis-generating and warrant prospective trials.
BACKGROUND: Catheter directed thrombolysis (CDT) and thrombectomy represent well established techniques for the treatment of intermediate pulmonary embolism (IPE). The long-term effect of catheter directed thrombolysis of IPE is unknown. METHODS: Clinical, interventional and echocardiographic data from 80 consecutive patients with IPE who were treated with CDT were evaluated. Primary end-points were technical success and major adverse events. Secondary end-points were cardiovascular mortality, all-cause mortality, clinical success, rate of bleeding complications, improvement in pulmonary pressure and echocardiography parameters. CDT completed with alteplase (10 mg bolus and 1 mg/h maintenance dose) through a pig-tail catheter for 24 h. After 24 h, control pulmonary angiography was performed. RESULTS: In total, 80 patients with a mean age of 59.0 ± 16.8 years were treated. CDT was successful after the first post-operative day in 72 (90%) patients, but thrombus aspiration and fragmentation was performed due to failed thrombolysis in 8 (10%) patients. Final technical and clinical success was reached in 79 (98.8%) and 77 (96.3%) patients, respectively. The mean CDT time in IPE was 27.8 ± 9.6 h. Invasive pulmonary pressure dropped from 57.5 ± 16.7 to 38.9 ± 13.5 (p < 0.001). A caval filter was implanted in 4 (5%) patients. The 1-year major adverse events and cardiovascular mortality rate was 4.0% and 1.4%, respectively. Access site complications (6 major and 6 minor) were encountered in 12 (16.2%) patients. CONCLUSIONS: Catheter directed thrombolysis in submassive pulmonary embolism had excellent results. However, additional mechanical thrombectomy was necessary in some patients to achieve good clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Ruzsa et al. (2020) conducted an observational in Intermediate pulmonary embolism (n=80). Catheter-directed thrombolysis and aspiration thrombectomy was evaluated on Final technical success. Catheter-directed thrombolysis in intermediate pulmonary embolism achieved a final technical success rate of 98.8% and a 1-year major adverse event rate of 4.0%, with additional mechanical thrombectomy required in 10% of patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: